ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and...
Molecular Partners, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, announced the strengthening of a previously...
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company announced the appointment of Dr. Andrew Cavey, as its Chief Executive Officer effective...
Eli Lilly and Company announced the successful completion of its acquisition of POINT Biopharma Global Inc., a radiopharmaceutical company with a pipeline of clinical...
